| Ms Diana P Behar, CAA | |
|
615 S New Ballas Rd Dept Of, Saint Louis, MO 63141-8221 | |
| (636) 386-9224 | |
| (636) 386-7679 |
| Full Name | Ms Diana P Behar |
|---|---|
| Gender | Female |
| Speciality | Anesthesiologist Assistant |
| Location | 615 S New Ballas Rd Dept Of, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972384931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 2023042639 (Missouri) | Primary |
| Entity Name | Western Anesthesiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275646754 PECOS PAC ID: 6204720667 Enrollment ID: O20040226000438 |
News Archive
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
The Journal of Nutrition Education and Behavior (JNEB) announces the 2012 Best Article and Best Great Educational Material (GEM) awards to be presented at the Society for Nutrition Education and Behavior (SNEB) annual conference, "Nutrition Education: Energy from Synergy," in Washington DC, July 14-17.
Scientists at the National Center for Atmospheric Research (NCAR) and partner organizations from across the country are launching a major field project on the northern Front Range of Colorado this month to track the origins of summertime ozone, an invisible but harmful pollutant.
Northwestern University researchers have discovered a drug that slows and may even halt the progression of Parkinson's disease.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Diana P Behar, CAA 339 Consort Dr, Ballwin, MO 63011-4439 Ph: (636) 386-9224 | Ms Diana P Behar, CAA 615 S New Ballas Rd Dept Of, Saint Louis, MO 63141-8221 Ph: (636) 386-9224 |
News Archive
A highly lethal cancer sometimes requires large doses of highly toxic drugs. However, a blitzkrieg approach can be unfeasible for some patients due to severe side effects. Now a powerhouse team of researchers at the University of North Carolina at Chapel Hill has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them - all while showing signs that the rest of the body would be spared toxic side effects.
The Journal of Nutrition Education and Behavior (JNEB) announces the 2012 Best Article and Best Great Educational Material (GEM) awards to be presented at the Society for Nutrition Education and Behavior (SNEB) annual conference, "Nutrition Education: Energy from Synergy," in Washington DC, July 14-17.
Scientists at the National Center for Atmospheric Research (NCAR) and partner organizations from across the country are launching a major field project on the northern Front Range of Colorado this month to track the origins of summertime ozone, an invisible but harmful pollutant.
Northwestern University researchers have discovered a drug that slows and may even halt the progression of Parkinson's disease.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.
› Verified 3 days ago
Jeremy Stephen Colyer, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 10010 Kennerly Rd, Saint Louis, MO 63128 Phone: 636-386-7222 Fax: 636-200-4036 | |
Mrs. Maria Jones, C-AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 615 S New Ballas Rd Dept Of, Saint Louis, MO 63141 Phone: 636-386-9224 Fax: 636-200-4243 | |
Alexander Sextro, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11133 Dunn Rd, Saint Louis, MO 63136 Phone: 314-653-5000 | |
Alexis Haas Stewart, Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 1465 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-977-5700 | |
Mr. Brian J Ho, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 615 S New Ballas Rd, Dept. Of Anesthesiology, Saint Louis, MO 63141 Phone: 314-251-4687 Fax: 636-200-4243 | |
Laheart Marie Rodney, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1465 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-268-7267 | |
Mr. Nick Balarama Rodriguez, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 615 S New Ballas Rd Dept Of, Saint Louis, MO 63141 Phone: 636-386-9224 Fax: 636-386-7679 |